Access Investment Management LLC acquired a new stake in Procter & Gamble Company (The) (NYSE:PG – Free Report) during the second quarter, HoldingsChannel reports. The fund acquired 562 shares of the company’s stock, valued at approximately $90,000.
Other large investors also recently bought and sold shares of the company. Brighton Jones LLC boosted its stake in shares of Procter & Gamble by 51.5% in the fourth quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock valued at $6,717,000 after buying an additional 13,617 shares in the last quarter. Taylor Financial Group Inc. lifted its holdings in Procter & Gamble by 10.6% in the first quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock valued at $493,000 after acquiring an additional 277 shares during the period. Summit Wealth Group LLC boosted its position in shares of Procter & Gamble by 11.2% during the 1st quarter. Summit Wealth Group LLC now owns 7,437 shares of the company’s stock worth $1,267,000 after purchasing an additional 752 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. grew its stake in shares of Procter & Gamble by 117.8% during the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 403 shares of the company’s stock worth $69,000 after purchasing an additional 218 shares during the period. Finally, Whelan Financial increased its holdings in shares of Procter & Gamble by 2.9% in the 1st quarter. Whelan Financial now owns 3,096 shares of the company’s stock valued at $528,000 after purchasing an additional 87 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Procter & Gamble Trading Up 0.7%
Shares of Procter & Gamble stock opened at $150.70 on Monday. The business’s fifty day moving average is $153.89 and its two-hundred day moving average is $157.77. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.46. Procter & Gamble Company has a fifty-two week low of $146.96 and a fifty-two week high of $180.43. The firm has a market cap of $352.14 billion, a PE ratio of 22.00, a P/E/G ratio of 3.87 and a beta of 0.36.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Friday, October 24th will be issued a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Friday, October 24th. Procter & Gamble’s dividend payout ratio (DPR) is 61.61%.
Insider Activity at Procter & Gamble
In other news, COO Shailesh Jejurikar sold 3,986 shares of the company’s stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $606,788.78. Following the completion of the sale, the chief operating officer directly owned 46,899 shares in the company, valued at $7,139,434.77. This represents a 7.83% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CAO Matthew W. Janzaruk sold 725 shares of Procter & Gamble stock in a transaction on Thursday, October 30th. The shares were sold at an average price of $149.57, for a total value of $108,438.25. Following the completion of the transaction, the chief accounting officer owned 979 shares in the company, valued at $146,429.03. The trade was a 42.55% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 150,488 shares of company stock worth $23,529,718. 0.20% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
Several research analysts have weighed in on the stock. Morgan Stanley set a $175.00 target price on shares of Procter & Gamble in a research report on Monday, October 27th. Bank of America dropped their price objective on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. BNP Paribas Exane decreased their target price on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research report on Tuesday, September 23rd. UBS Group dropped their price target on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. Finally, BNP Paribas reiterated an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. Twelve analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average target price of $171.53.
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
- Five stocks we like better than Procter & Gamble
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 3 Safe and Steady Stocks for Any Market
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Is Lemonade Stock Set for a Big Squeeze After Earnings?
- How to find penny stocks to invest and trade
- Caterpillar Stock Could Top $650 by Year’s End
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
